|
HRP20140049T1
(hr)
|
2007-01-05 |
2014-02-28 |
University Of Zürich |
Anti beta-amiloid antitijela i njihova upotreba
|
|
SI2436696T1
(sl)
*
|
2007-01-05 |
2017-10-30 |
University Of Zurich |
Anti-beta-amiloidno protitelo in načini njegove uporabe
|
|
JPWO2009051220A1
(ja)
*
|
2007-10-19 |
2011-03-03 |
イムナス・ファーマ株式会社 |
Ａβオリゴマーに特異的に結合する抗体およびその利用
|
|
CA2714413C
(en)
|
2008-02-08 |
2017-01-24 |
Immunas Pharma, Inc. |
Antibody capable of binding specifically to ab-oligomer, and use thereof
|
|
CA2730073A1
(en)
*
|
2008-07-09 |
2010-01-14 |
University Of Zurich |
Method of promoting neurogenesis
|
|
EA030826B1
(ru)
|
2008-12-19 |
2018-10-31 |
Панима Фармасьютикалз Аг |
ЧЕЛОВЕЧЕСКИЕ АУТОАНТИТЕЛА ПРОТИВ α-СИНУКЛЕИНА
|
|
JP5812418B2
(ja)
|
2009-04-17 |
2015-11-11 |
イムナス・ファーマ株式会社 |
Ａβオリゴマーに特異的に結合する抗体およびその利用
|
|
JP5599454B2
(ja)
|
2009-08-06 |
2014-10-01 |
イムナス・ファーマ株式会社 |
Ａβオリゴマーに特異的に結合する抗体およびその利用
|
|
CN103037900B
(zh)
|
2010-02-24 |
2016-04-06 |
伊缪诺金公司 |
叶酸受体1抗体与免疫缀合物以及其用途
|
|
RU2013131825A
(ru)
|
2011-01-10 |
2015-02-20 |
Зе Реджентс Оф Зе Юниверсити Оф Мичиган |
Ингибитор фактора стволовых клеток
|
|
PT2663579T
(pt)
|
2011-01-14 |
2017-07-28 |
Univ California |
Terapêutica de anticorpos contra a proteína r0r-1 e métodos para sua utilização
|
|
CA2831426C
(en)
*
|
2011-04-01 |
2023-02-21 |
Immunogen, Inc. |
Methods for increasing efficacy of folr1 cancer therapy
|
|
ES2699801T3
(es)
|
2011-06-23 |
2019-02-12 |
Biogen Int Neuroscience Gmbh |
Moléculas de unión anti-alfa sinucleína
|
|
GB201110938D0
(en)
*
|
2011-06-27 |
2011-08-10 |
Iti Scotland Ltd |
Compounds
|
|
US20140377288A1
(en)
*
|
2011-09-16 |
2014-12-25 |
The Board Of Regents Of The University Of Texas System |
Compositions and methods related to dna damage repair
|
|
CN104755498B
(zh)
*
|
2012-08-31 |
2019-06-18 |
伊缪诺金公司 |
用于检测叶酸受体1的诊断测定和试剂盒
|
|
AU2013361231A1
(en)
*
|
2012-12-19 |
2015-06-04 |
Amplimmune, Inc. |
B7-H4 specific antibodies, and compositions and methods of use thereof
|
|
US9534044B2
(en)
*
|
2013-02-28 |
2017-01-03 |
United Arab Emirates University |
Alpha-synuclein antibodies and uses thereof
|
|
WO2015006554A1
(en)
*
|
2013-07-10 |
2015-01-15 |
The Regents Of The University Of Michigan |
Therapeutic antibodies and uses thereof
|
|
CN114621346B
(zh)
*
|
2013-08-21 |
2025-06-10 |
德克萨斯州大学系统董事会 |
用于靶向连接蛋白半通道的组合物和方法
|
|
US9637547B2
(en)
|
2013-08-30 |
2017-05-02 |
Immunogen, Inc. |
Monoclonal antibodies for detection of folate receptor 1
|
|
EP3054974A4
(en)
*
|
2013-10-10 |
2017-06-14 |
Siamab Therapeutics, Inc. |
Glycan-interacting compounds and methods of use
|
|
WO2015065987A1
(en)
*
|
2013-11-01 |
2015-05-07 |
Ibc Pharmaceuticals, Inc. |
Bispecific antibodies that neutralize both tnf-alpha and il-6: novel therapeutic agent for autoimmune disease
|
|
AU2015213735A1
(en)
*
|
2014-02-10 |
2016-08-04 |
Merck Sharp & Dohme Corp. |
Antibodies that bind to human Tau and assay for quantifying human Tau using the antibodies
|
|
EP3119805A1
(en)
|
2014-03-20 |
2017-01-25 |
Wellstat Diagnostics, LLC |
Antibodies and methods for the detection of cell death
|
|
CN106456727B
(zh)
*
|
2014-04-10 |
2020-11-27 |
台湾浩鼎生技股份有限公司 |
抗体、产生所述抗体的杂交瘤、及其用途
|
|
CN113583131B
(zh)
|
2014-08-19 |
2024-09-03 |
默沙东有限责任公司 |
抗tigit抗体
|
|
JP2017532953A
(ja)
|
2014-09-16 |
2017-11-09 |
オバサイエンス・インコーポレイテッド |
抗ｖａｓａ抗体、ならびにその産生法および使用法
|
|
EP3207057A2
(en)
*
|
2014-10-16 |
2017-08-23 |
F. Hoffmann-La Roche AG |
Anti-alpha-synuclein antibodies and methods of use
|
|
US9879087B2
(en)
|
2014-11-12 |
2018-01-30 |
Siamab Therapeutics, Inc. |
Glycan-interacting compounds and methods of use
|
|
CA2967595A1
(en)
|
2014-11-12 |
2016-05-19 |
Siamab Therapeutics, Inc. |
Glycan-interacting compounds and methods of use
|
|
MA41115A
(fr)
|
2014-12-02 |
2017-10-10 |
Biogen Int Neuroscience Gmbh |
Procédé de traitement de la maladie d'alzheimer
|
|
ES2870983T3
(es)
*
|
2014-12-19 |
2021-10-28 |
Univ Nantes |
Anticuerpos anti-IL-34
|
|
CN107531781B
(zh)
*
|
2015-01-29 |
2021-12-07 |
抗菌技术,生物技术研究与发展股份有限公司 |
用于阿尔茨海默病和相关紊乱的抗体分子和肽递送系统
|
|
US10494425B2
(en)
*
|
2015-02-24 |
2019-12-03 |
Rpeptide, Llc |
Anti-amyloid-beta antibodies
|
|
US10517948B2
(en)
|
2015-03-11 |
2019-12-31 |
The Board Of Regents Of The University Of Texas System |
Anti-DC-HIL antibodies for cancer diagnosis, prognosis and therapy
|
|
WO2016149116A1
(en)
*
|
2015-03-13 |
2016-09-22 |
University Of Maryland, Baltimore |
Antibodies targeting s100b and methods of use
|
|
ES2904573T3
(es)
*
|
2015-03-27 |
2022-04-05 |
Univ Southern California |
Terapia con células T dirigida a LHR para el tratamiento de tumores sólidos
|
|
US10487153B2
(en)
*
|
2015-06-10 |
2019-11-26 |
National Research Council Of Canada |
Carbonic anhydrase IX-specific antibodies and uses thereof
|
|
WO2016205566A1
(en)
*
|
2015-06-16 |
2016-12-22 |
The Regents Of The University Of California |
Fzd7 specific antibodies and vaccines to treat cancer and control stem cell function
|
|
CN108290936B
(zh)
*
|
2015-08-14 |
2022-07-12 |
默沙东公司 |
抗tigit抗体
|
|
RU2021133819A
(ru)
|
2015-09-02 |
2021-12-10 |
Иммутеп С.A.С. |
Анти-lag-3 антитела
|
|
IL257531B2
(en)
|
2015-09-17 |
2023-04-01 |
Immunogen Inc |
Medicinal compositions containing anti-folr1 immunoconjugates
|
|
EP3374379A4
(en)
|
2015-11-09 |
2019-05-15 |
The University Of British Columbia |
N-TERMINAL EPITOPES IN AMYLOID BETA AND CONFORMATION-SELECTIVE ANTIBODIES
|
|
JP7448174B2
(ja)
|
2015-11-09 |
2024-03-12 |
ザ・ユニバーシティ・オブ・ブリティッシュ・コロンビア |
アミロイドベータ中間領域エピトープおよびそれに対する立体配座選択的抗体
|
|
CA3004498A1
(en)
|
2015-11-09 |
2017-05-18 |
Neil R. Cashman |
Amyloid beta epitopes and antibodies thereto
|
|
CA3002097A1
(en)
|
2015-11-12 |
2017-05-18 |
Siamab Therapeutics, Inc. |
Glycan-interacting compounds and methods of use
|
|
AU2017228474C1
(en)
|
2016-03-04 |
2024-03-28 |
Abmuno Therapeutics Llc |
Antibodies to TIGIT
|
|
IL261802B2
(en)
*
|
2016-03-16 |
2024-01-01 |
Abeome Corp |
Neutralizing monoclonal antibodies to IL-25 and their use
|
|
US20180362660A1
(en)
*
|
2016-05-09 |
2018-12-20 |
Schickwann Tsai |
Anti-penumbra monoclonal antibodies for detection and therapy of normal and abnormal B lymphocytes
|
|
WO2017218691A1
(en)
|
2016-06-16 |
2017-12-21 |
The Board Of Trustees Of The Leland Stanford Junior University |
Humanized and chimeric monoclonal antibodies to cd81
|
|
KR102550991B1
(ko)
*
|
2016-07-18 |
2023-07-04 |
더 유니버시티 오브 브리티쉬 콜롬비아 |
아밀로이드 베타에 대한 항체
|
|
JOP20170154B1
(ar)
*
|
2016-08-01 |
2023-03-28 |
Omeros Corp |
تركيبات وطرق لتثبيط masp-3 لعلاج أمراض واضطرابات مختلفة
|
|
TW201827467A
(zh)
|
2016-11-03 |
2018-08-01 |
比利時商健生藥品公司 |
焦穀胺酸類澱粉蛋白－β之抗體及其用途
|
|
US20180125920A1
(en)
|
2016-11-09 |
2018-05-10 |
The University Of British Columbia |
Methods for preventing and treating A-beta oligomer-associated and/or -induced diseases and conditions
|
|
EP3541847A4
(en)
|
2016-11-17 |
2020-07-08 |
Seattle Genetics, Inc. |
COMPOUNDS INTERACTING WITH GLYCANE AND METHODS OF USE
|
|
JP7274417B2
(ja)
|
2016-11-23 |
2023-05-16 |
イミュノア・セラピューティクス・インコーポレイテッド |
４－１ｂｂ結合タンパク質及びその使用
|
|
CN106749657A
(zh)
*
|
2016-12-13 |
2017-05-31 |
中国农业科学院哈尔滨兽医研究所 |
一种抗体信号肽及其应用
|
|
EP3585403A4
(en)
*
|
2017-02-22 |
2020-12-09 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
CHEMERICAL ANTIGENIC RECEPTORS BINDING TO TIM3
|
|
WO2018158398A1
(en)
*
|
2017-03-02 |
2018-09-07 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Antibodies having specificity to nectin-4 and uses thereof
|
|
JP2020510671A
(ja)
|
2017-03-03 |
2020-04-09 |
シアトル ジェネティックス， インコーポレイテッド |
グリカン相互作用化合物および使用の方法
|
|
EP3608335A4
(en)
*
|
2017-04-05 |
2020-04-29 |
XDCExplorer (Shanghai) Co., Ltd. |
HUMANIZED ANTI-TPBG ANTIBODY, PRODUCTION METHOD THEREFOR, CONJUGATE THEREOF AND APPLICATIONS
|
|
JP7280238B2
(ja)
*
|
2017-07-17 |
2023-05-23 |
ヤンセン バイオテツク，インコーポレーテツド |
フィブロネクチンｉｉｉ型ドメインに対する抗原結合領域及びその使用方法
|
|
US12286469B2
(en)
|
2017-07-18 |
2025-04-29 |
The University Of British Columbia |
Humanized antibodies binding to amyloid-beta (A-beta)
|
|
AU2018308088B2
(en)
|
2017-07-25 |
2025-05-29 |
Truebinding, Inc. |
Treating cancer by blocking the interaction of TIM-3 and its ligand
|
|
MA49947B1
(fr)
|
2017-08-22 |
2023-03-31 |
Biogen Ma Inc |
Compositions pharmaceutiques contenant des anticorps anti-bêta-amyloïdes
|
|
US20200017596A1
(en)
*
|
2018-05-10 |
2020-01-16 |
Abvision, Inc. |
Monoclonal antibodies activating cd40 and uses thereof
|
|
CN112601550B
(zh)
*
|
2018-05-30 |
2023-12-08 |
财团法人卫生研究院 |
抗-乙型淀粉样蛋白抗体及其用途
|
|
AU2019287720B2
(en)
|
2018-06-14 |
2025-08-28 |
Regeneron Pharmaceuticals, Inc. |
CD79A chimeric antigen receptors
|
|
WO2020016661A2
(en)
*
|
2018-07-09 |
2020-01-23 |
Multitude Inc. |
Antibodies specific to folate receptor alpha
|
|
CN119638835A
(zh)
*
|
2018-09-17 |
2025-03-18 |
布里格姆妇女医院 |
抗klrg1抗体
|
|
CN113508137B
(zh)
*
|
2019-01-29 |
2024-12-20 |
上海交通大学 |
一种嵌合抗原受体及其应用
|
|
CA3127113A1
(en)
|
2019-01-30 |
2020-08-06 |
Dongxu Sun |
Anti-gal3 antibodies and uses thereof
|
|
CA3132462A1
(en)
*
|
2019-03-02 |
2020-09-10 |
The Board Of Trustees Of The Leland Stanford Junior University |
Therapeutic antigen binding proteins specific for cd93 and methods of use thereof
|
|
CA3134785A1
(en)
|
2019-03-26 |
2020-10-01 |
Janssen Pharmaceutica Nv |
Antibodies to pyroglutamate amyloid-.beta. and uses thereof
|
|
CN110343180B
(zh)
*
|
2019-07-25 |
2021-03-30 |
北京免疫方舟医药科技有限公司 |
抗ctla-4抗体及其应用
|
|
US12352719B2
(en)
|
2019-09-20 |
2025-07-08 |
KYCERA AVX Components Corporation |
Somatic cell-based electrical biosensor
|
|
CN111808191A
(zh)
*
|
2020-05-11 |
2020-10-23 |
廊坊天光生物技术有限公司 |
一种用于检测血清中vegf含量的抗体对及其用途
|
|
CN111793136A
(zh)
*
|
2020-05-11 |
2020-10-20 |
廊坊天光生物技术有限公司 |
一种nmp22抗体对及其应用
|
|
US20230340089A1
(en)
*
|
2020-05-14 |
2023-10-26 |
City Of Hope |
Smc1a antibodies and uses thereof
|
|
AU2021278935A1
(en)
|
2020-05-26 |
2022-12-08 |
Truebinding, Inc. |
Methods of treating inflammatory diseases by blocking Galectin-3
|
|
KR20230019152A
(ko)
|
2020-06-02 |
2023-02-07 |
아르커스 바이오사이언시즈 인코포레이티드 |
Tigit에 대한 항체
|
|
CN116723856A
(zh)
|
2020-06-25 |
2023-09-08 |
默沙东有限责任公司 |
靶向丝氨酸413处磷酸化的tau的高亲和力抗体
|
|
UY39337A
(es)
|
2020-07-23 |
2022-02-25 |
Othair Prothena Ltd |
Anticuerpos anti-abeta
|
|
CA3187837A1
(en)
*
|
2020-08-04 |
2022-02-10 |
Exelixis, Inc. |
Cd47 binding agents and uses thereof
|
|
CA3189666A1
(en)
*
|
2020-08-18 |
2022-02-24 |
William Jason Cummings |
Monoclonal antibodies, compositions and methods for detecting complement factor d
|
|
CN112778419A
(zh)
*
|
2021-02-01 |
2021-05-11 |
重庆中元汇吉生物技术有限公司 |
抗ck-mb的抗体或其抗原结合部分及其应用
|
|
WO2022174103A2
(en)
*
|
2021-02-11 |
2022-08-18 |
The Regents Of The University Of California |
Monoclonal antibodies specific for human ror1
|
|
CN113075398A
(zh)
*
|
2021-03-23 |
2021-07-06 |
中国医学科学院输血研究所 |
一种血浆中特异性IgG抗体的定量测定方法
|
|
US20250180551A1
(en)
*
|
2021-10-26 |
2025-06-05 |
Bach Diagnostics Inc. |
Lateral flow assay for the diagnosis of dermatomycosis
|
|
CN120344262A
(zh)
*
|
2022-11-08 |
2025-07-18 |
凡恩世制药(北京)有限公司 |
抗-5t4抗体及用途
|
|
US20240247077A1
(en)
*
|
2023-01-23 |
2024-07-25 |
Clemson University Research Foundation |
Cyp1a1-targeted monoclonal antibody with reactivity across vertebrate taxa
|
|
EP4655320A1
(en)
*
|
2023-01-27 |
2025-12-03 |
The United States Government As Represented By The Department Of Veterans Affairs |
Compositions for treating tauopathies and methods of use thereof
|
|
AU2024227909A1
(en)
*
|
2023-02-28 |
2025-08-14 |
Mayo Foundation For Medical Education And Research |
Molecules that bind to b-cell activating factor receptor polypeptides
|
|
CN119306826B
(zh)
*
|
2023-07-11 |
2025-06-20 |
东莞市朋志生物科技有限公司 |
抗白介素-6抗体、检测白介素-6的试剂和试剂盒
|
|
WO2025044931A1
(zh)
*
|
2023-08-25 |
2025-03-06 |
康诺亚生物医药科技（成都）有限公司 |
阿尔茨海默病治疗剂的开发和应用
|
|
CN119613538B
(zh)
*
|
2024-12-12 |
2025-10-17 |
浙江大学医学院附属第一医院(浙江省第一医院) |
抗h10亚型流感病毒血凝素蛋白中和性单克隆抗体1e10及其应用
|
|
CN120209138B
(zh)
*
|
2025-05-29 |
2025-10-03 |
杭州广科安德生物科技有限公司 |
Tff3、osm蛋白的抗体及其组合和在结直肠癌诊断中的应用
|